Skip to content
value.today

Radius Health, Inc.

🇺🇸 Cambridge, Massachusetts, USAPharmaceuticalsFounded 2008

Formerly MPM ACQUISITION CORP.

Funding rounds

0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Radius Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2011$64 MIssued in a merger or acquisition$50 to $250 million

Radius Health, Inc.: Private sale, May 2011

Investors in this round

18 investors had bought by the notice of May 31, 2011: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 25 investors are named for Radius Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$64 M of $64 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-1 Convertible Preferred Stock
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$434,868
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • B. Nicholas Harvey · Executive Officer, Promoter · Mr. Harvey is a Senior Vice President, Chief Financial Officer, the Treasurer and Secretary of the Issuer.
  • C. Richard Lyttle · Executive Officer, Director, Promoter · Dr. Lyttle is the President, Chief Executive Office and a Director of the Issuer.
  • Gary Nicholas Hattersley · Executive Officer, Promoter · Dr. Hattersley is a Vice President of the Issuer.
  • Louis Nicholas O'Dea · Executive Officer, Promoter · Dr. O'Dea is a Senior Vice President and the Chief Medical Officer of the Issuer.
  • Alan Nicholas Auerbach · Director, Promoter · Mr. Auerbach is a director of the Issuer.
  • Ansbert K. Gadicke · Director, Promoter · Dr. Ansbert is a director of the Issuer.
  • Elizabeth K. Stoner · Director, Promoter · Dr. Stoner is a director of the Issuer.
  • Jonathan Nicholas Fleming · Director · Mr. Fleming is a director of the Issuer.
  • Kurt K. Graves · Director, Promoter · Mr. Graves is a director of the Issuer.
  • Martin K. Muenchbach · Director, Promoter · Dr. Muenchbach is a director of the Issuer.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Leerink Swann LLC (CRD 39011) · broker-dealer Leerinks Swann LLC (CRD 39011) · Bostin, MassachusettsSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY

Remarks in the notice

  • On fees: “The amount in Item 15 is for sales commission on the first capital call received and does not reflect commissions on future capital calls.”
  • On the amounts: “Represents the total amount of securities to be sold under a stock purchase agreement whereby the Issuer will issue a capital call on the purchase price and issue the securities in three stages.”
  • On a merger: “For details on this offering, reference is made to the Issuer's Form 8-K dated May 17, 2011, filed on May 23, 2011 at CIK# 0001428522.”

Signed by B. Nicholas Harvey, Sr. Vice President, Secretary, Treasurer and Chief Financial. Newest notice filed May 31, 2011 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Radius Health, Inc. had no revenue when it filed its newest notice of a funding round (May 2011).

    SEC Form D (revenue range) · May 2011

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · May 2011

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

25 named in official filings. Open an investor to see everything it has backed.

Investors in Radius Health, Inc.
InvestorKindAmountRoundRoleSource
BB Biotech AGCompanynot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
F2 Bioscience GP Ltd.Companynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
F2 Bioscience III, L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
F2 Bioscience IV GP Ltd.Companynot statednot statedHeld Series B-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
F2 Bioscience IV L.P.Fund or asset managernot statednot statedHeld Series B-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
F2 Bio Ventures GP Ltd.Venture capitalnot statednot statedHeld Series B-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
F2 Bio Ventures V L.P.Venture capitalnot statednot statedHeld Series B-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
F2 Capital LtdFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2013)SEC Form 3
Globeways Holdings LtdCompanynot statednot statedHeld Series B-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
HealthCare Partners VII, L.P.Fund or asset managernot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Healthcare Private Equity Limited PartnershipPrivate equitynot statednot statedHeld Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2012)SEC Form 3
Healthcare Ventures VII LPVenture capitalnot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Ipsen, S.A.Companynot statednot statedHeld Series A-1 preferred stock (Form 3, 2011)SEC Form 3
MPM Asset Management Investors 2003 Bviii LLCFund or asset managernot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM Bio IV NVS Strategic Fund LPFund or asset managernot statednot statedHeld Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM BIOVENTURES III GMBH & CO. Beteiligungs KGVenture capitalnot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM Bioventures III GP L.P.Venture capitalnot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM Bioventures III LLCVenture capitalnot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM Bioventures III L.P.Venture capitalnot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM Bioventures III Parallel Fund, L.P.Venture capitalnot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM Bioventures III-Qp L.P.Venture capitalnot statednot statedHeld Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM BioVentures IV GP LLCVenture capitalnot statednot statedHeld Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
MPM BioVentures IV LLCVenture capitalnot statednot statedHeld Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Nordic Bioscience Clinical Development VII A/SPersonnot statednot statedHeld Series A-5 and A-6 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUSTFund or asset managernot statednot statedHeld Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011)SEC Form 3

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Radius Health, Inc.
NameRoleNamed in
B. Nicholas HarveyMr. Harvey is a Senior Vice President, Chief Financial Officer, the Treasurer and Secretary of the Issuer.May 2011
C. Richard LyttleDr. Lyttle is the President, Chief Executive Office and a Director of the Issuer.May 2011
Gary Nicholas HattersleyDr. Hattersley is a Vice President of the Issuer.May 2011
Louis Nicholas O'DeaDr. O'Dea is a Senior Vice President and the Chief Medical Officer of the Issuer.May 2011
Alan Nicholas AuerbachMr. Auerbach is a director of the Issuer.May 2011
Ansbert K. GadickeDr. Ansbert is a director of the Issuer.May 2011
C. Richard LyttleDr. Lyttle is the President, Chief Executive Office and a Director of the Issuer.May 2011
Elizabeth K. StonerDr. Stoner is a director of the Issuer.May 2011
Jonathan Nicholas FlemingMr. Fleming is a director of the Issuer.May 2011
Kurt K. GravesMr. Graves is a director of the Issuer.May 2011
Martin K. MuenchbachDr. Muenchbach is a director of the Issuer.May 2011
Alan Nicholas AuerbachMr. Auerbach is a director of the Issuer.May 2011
Ansbert K. GadickeDr. Ansbert is a director of the Issuer.May 2011
B. Nicholas HarveyMr. Harvey is a Senior Vice President, Chief Financial Officer, the Treasurer and Secretary of the Issuer.May 2011
C. Richard LyttleDr. Lyttle is the President, Chief Executive Office and a Director of the Issuer.May 2011
Elizabeth K. StonerDr. Stoner is a director of the Issuer.May 2011
Gary Nicholas HattersleyDr. Hattersley is a Vice President of the Issuer.May 2011
Kurt K. GravesMr. Graves is a director of the Issuer.May 2011
Louis Nicholas O'DeaDr. O'Dea is a Senior Vice President and the Chief Medical Officer of the Issuer.May 2011
Martin K. MuenchbachDr. Muenchbach is a director of the Issuer.May 2011